| Primary |
| Tuberculosis |
65.8% |
| Drug Use For Unknown Indication |
7.9% |
| Depression |
5.3% |
| Psychotic Disorder |
5.3% |
| Bipolar Disorder |
2.6% |
| Insomnia |
2.6% |
| Mental Disorder |
2.6% |
| Schizoaffective Disorder |
2.6% |
| Schizoaffective Disorder Bipolar Type |
2.6% |
| Schizophrenia |
2.6% |
|
| Cardio-respiratory Arrest |
11.5% |
| Epilepsy |
11.5% |
| Optic Neuritis |
7.7% |
| Transaminases Increased |
7.7% |
| Blindness |
3.8% |
| Coma |
3.8% |
| Death |
3.8% |
| Hepatic Enzyme Increased |
3.8% |
| Maternal Drugs Affecting Foetus |
3.8% |
| Medication Error |
3.8% |
| Neuropathy Peripheral |
3.8% |
| Paraesthesia |
3.8% |
| Parkinsonism |
3.8% |
| Respiratory Rate Increased |
3.8% |
| Tardive Dyskinesia |
3.8% |
| Thrombocytopenia |
3.8% |
| Tourette's Disorder |
3.8% |
| Treatment Noncompliance |
3.8% |
| Unevaluable Event |
3.8% |
| Vanishing Bile Duct Syndrome |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
31.4% |
| Tuberculosis |
31.0% |
| Drug Use For Unknown Indication |
12.5% |
| Schizophrenia, Paranoid Type |
3.3% |
| Schizophrenia |
2.6% |
| Delusion |
2.2% |
| Anxiety |
1.8% |
| Hypochondriasis |
1.8% |
| Psychiatric Symptom |
1.8% |
| Amnestic Disorder |
1.5% |
| Bipolar Disorder |
1.5% |
| Bronchitis |
1.5% |
| Dementia Alzheimer's Type |
1.5% |
| Acute Psychosis |
1.1% |
| Angina Pectoris |
0.7% |
| Convulsion |
0.7% |
| Diuretic Therapy |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Meniere's Disease |
0.7% |
| Pain |
0.7% |
|
| Pancytopenia |
13.8% |
| Polyneuropathy |
13.8% |
| Anaemia |
6.9% |
| Renal Failure Acute |
6.9% |
| Respiratory Arrest |
6.9% |
| Acute Hepatic Failure |
5.2% |
| Neuroleptic Malignant Syndrome |
5.2% |
| Tremor |
5.2% |
| Vomiting |
5.2% |
| Cardio-respiratory Arrest |
3.4% |
| Hypotension |
3.4% |
| Myocardial Infarction |
3.4% |
| Somnolence |
3.4% |
| Suicide Attempt |
3.4% |
| Thrombocytopenia |
3.4% |
| Treatment Noncompliance |
3.4% |
| Acute Myeloid Leukaemia |
1.7% |
| Blood Creatine Phosphokinase Increased |
1.7% |
| Cognitive Disorder |
1.7% |
| Completed Suicide |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.3% |
| Product Used For Unknown Indication |
12.7% |
| Depression |
10.0% |
| Schizophrenia |
9.3% |
| Anxiety |
7.2% |
| Pain |
5.2% |
| Constipation |
4.5% |
| Sleep Disorder |
4.5% |
| Psychotic Disorder |
3.1% |
| Bipolar Disorder |
2.7% |
| Hypothyroidism |
2.7% |
| Intervertebral Disc Degeneration |
2.7% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Malignant Melanoma |
2.4% |
| Hyperlipidaemia |
2.1% |
| Nausea |
2.1% |
| Insomnia |
1.7% |
| Vitamin Supplementation |
1.7% |
| Affective Disorder |
1.4% |
| Anticoagulant Therapy |
1.4% |
|
| Suicidal Ideation |
16.7% |
| Type 2 Diabetes Mellitus |
8.3% |
| Vomiting |
8.3% |
| Weight Increased |
8.3% |
| Withdrawal Syndrome |
8.3% |
| Vaginal Infection |
6.0% |
| Agitation |
4.8% |
| Premature Baby |
4.8% |
| Cardiac Death |
3.6% |
| Drug Ineffective |
3.6% |
| Granulocytopenia |
3.6% |
| Tearfulness |
3.6% |
| Trigeminal Neuralgia |
3.6% |
| Aggression |
2.4% |
| Convulsion |
2.4% |
| Depression |
2.4% |
| Drug Interaction |
2.4% |
| Drug Withdrawal Syndrome |
2.4% |
| Fatigue |
2.4% |
| General Physical Health Deterioration |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
|
